ロード中...
Intravenous Zoledronate for a Patient with Paget's Disease
Paget's disease (PD) of bone is characterized by increase of bone resorption by atypical osteoclasts, followed by rapid new bone formation resulting in a disorganized mosaic bone. Although the pathophysiology is not fully understood, bisphosphonate, which is a potent anti-resorptive agent for t...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
The Korean Society for Bone and Mineral Research
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4170086/ https://ncbi.nlm.nih.gov/pubmed/25247161 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.11005/jbm.2014.21.3.223 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|